...
首页> 外文期刊>Cell death & disease. >Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6
【24h】

Artesunate induces mitochondria-mediated apoptosis of human retinoblastoma cells by upregulating Kruppel-like factor 6

机译:青蒿琥酯通过上调kruppel样系数6诱导人视网膜细胞瘤细胞的线粒体介导的细胞凋亡

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Retinoblastoma (RB) is the most common primary intraocular malignancy in children. Intravitreal chemotherapy achieves favorable clinical outcomes in controlling RB vitreous seeds, which are a common reason for treatment failure. Thus, a novel, effective and safe intravitreal chemotherapeutic drug is urgently required. The malaria drug artesunate (ART) recently demonstrated remarkable anticancer effects with mild side effects. The purpose of this study is to investigate the anti-RB efficacy, the underlying mechanism and the intraocular safety of ART. Herein, we verified that ART inhibits RB cell viability and induces cell apoptosis in a dose- and time-dependent manner. Microarray analysis revealed that Kruppel-like factor 6 (KLF6) was upregulated after ART treatment, and this was further confirmed by real-time PCR and western blot assays. Silencing of KLF6 expression significantly reversed ART-induced RB cell growth inhibition and apoptosis. Furthermore, ART activated mitochondria-mediated apoptosis of RB cells, while silencing KLF6 expression significantly inhibited this effect. In murine xenotransplantation models of RB, we further confirmed that ART inhibits RB tumor growth, induces tumor cell apoptosis and upregulates KLF6 expression. In addition, KLF6 silencing attenuates ART-mediated inhibition of tumor growth in vivo. Furthermore, we proved that intravitreal injection of ART in Sprague-Dawley (SD) rats is safe, with no obvious retinal function damage or structural disorders observed by electrophysiology (ERG), fundal photographs, fundus fluorescein angiography (FFA) or optical coherence tomography (OCT) examinations. Collectively, our study revealed that ART induces mitochondrial apoptosis of RB cells via upregulating KLF6, and our results may extend the application of ART to the clinic as an effective and safe intravitreal chemotherapeutic drug to treat RB, especially RB with vitreous seeds.
机译:视网膜母细胞瘤(RB)是儿童中最常见的主要眼内恶性肿瘤。玻璃体内化疗在控制RB玻璃体种子中实现有利的临床结果,这是治疗失败的常见原因。因此,迫切需要新型,有效和安全的玻璃体内化学治疗药物。疟疾药物artesunate(艺术)最近展示了具有轻度副作用的显着抗癌影响。本研究的目的是探讨抗RB功效,潜在机制和艺术的眼内安全性。在此,我们验证了该技术抑制RB细胞活力并以剂量和时间依赖的方式诱导细胞凋亡。微阵列分析表明,在本领域的处理后上调了Kruppel样因子6(KLF6),并且通过实时PCR和Western印迹测定进一步证实了这一点。 KLF6表达的沉默显着逆转艺术诱导的RB细胞生长抑制和细胞凋亡。此外,艺术活性线粒体介导的RB细胞凋亡,同时沉默KLF6表达显着抑制了这种效果。在鼠异叶植物持续模型的RB中,我们进一步证实,技术抑制RB肿瘤生长,诱导肿瘤细胞凋亡并上调KLF6表达。此外,KLF6沉默衰减艺术介导的抑制体内肿瘤生长。此外,我们证明,Sprague-Dawley(SD)大鼠玻璃体内注射艺术是安全的,通过电生理学(ERG),基底照片,眼底荧光血管造影(FFA)或光学相干断层造影(FFA)或光学相干断层造影(FFA)或光学相干断层造影(FFA)或光学相干断层造影(FFA)或光学相干断层造影(FFA)或光学相干断层造影(FFA)或光学相干断层扫描(FFA)或光学相干断层扫描(FFA)或光学相干断层造影(FFA)或光学相干断层术( OCT)考试。专注于,我们的研究表明,技术通过上调KLF6诱导RB细胞的线粒体细胞凋亡,我们的结果可以将艺术的应用扩展到临床中作为一种有效和安全的玻璃体内化学治疗药物来治疗RB,特别是具有玻璃体的RB,特别是RB。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号